It’s 2018 – some important events to watch out for this year

Happy New Year to you all. To get your year off to a good start, here are a few important dates for your new 2018 diary. February 1 – 3 ACTRIMS Forum, San Diego, California, USA The third annual Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum is themed “Therapeutic Targets in … Continue reading It’s 2018 – some important events to watch out for this year

Ibudilast slows both brain shrinkage and loss of myelin in MS, phase 2 trial shows

Multiple sclerosis organisations, and the media, are excited about new drug ibudilast. This follows a striking presentation at the ECTRIMS-ACTRIMS meeting in Paris. So, what exactly is ibudilast and what can it do? Well, it’s an ant-inflammatory treatment but, for a more detailed answer, I am grateful to multiplescleroisnewstoday.com for this explanation: “Ibudilast, labeled MN-166 by MediciNova, is … Continue reading Ibudilast slows both brain shrinkage and loss of myelin in MS, phase 2 trial shows

One MS event closes as another starts in the same venue, it’s all happening next month

MS Life, billed as the big-gest MS lifestyle event in Europe, is set to begin at lunchtime on Saturday September 17 just as the 32nd congress of ECTRIMS, the European Committee for Treatment and Research in Multiple Sclerosis1, draws to a close in the very same venue – the ExCel, in London. More than 8,000 researchers … Continue reading One MS event closes as another starts in the same venue, it’s all happening next month